Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History MNPR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics MNPR

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Monopar Therapeutics Inc

MNPR
Current price
40.44 USD +1.07 USD (+2.72%)
Last closed 37.20 USD
ISIN US61023L2079
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 221 676 368 USD
Yield for 12 month +1 048.86 %
1Y
3Y
5Y
10Y
15Y
MNPR
21.11.2021 - 28.11.2021

Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary humanized monoclonal antibody that is conjugated with different radioisotopes for the treatment of advanced solid tumors expressing urokinase plasminogen activator receptor; and MNPR-101-Zr, a clinical-stage radiodiagnostic imaging agent comprised of MNPR-101 conjugated to zirconium-89. It develops MNPR-101-Lu, a late-preclinical stage radiotherapeutic comprised of MNPR-101 conjugated to actinium-225. The company has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19. The company was founded in 2014 and is headquartered in Wilmette, Illinois. Address: 1000 Skokie Boulevard, Wilmette, IL, United States, 60091

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

61.02 USD

P/E Ratio

Dividend Yield

Financials MNPR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures MNPR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

EBITDA
Operating Margin TTM
Price to Earnings
Return On Assets TTM -34.49 %
PEG Ratio
Return On Equity TTM -54.27 %
Wall Street Target Price 61.02 USD
Revenue TTM
Book Value 8.76 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -3.98 USD
Diluted Eps TTM -3.98 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation MNPR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -2.42
Price Book MRQ 4.14

Technical Indicators MNPR

For 52 Weeks

1.72 USD 54.30 USD
50 Day MA 36.48 USD
Shares Short Prior Month 34 004
200 Day MA 28.24 USD
Short Ratio 1.07
Shares Short 25 155
Short Percent 1.30 %